NPI Details
Peter Buffa, M.D. is an internal medicine in Bethpage, NY with 30 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Peter Buffa, M.D. NPI is 1790884344. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Graduation Year:1996
The provider's business location address is:
4277 HEMPSTEAD TPKE
SUITE 209
BETHPAGE, NY
ZIP 11714-709
Phone: (516) 731-7770
Fax: (516) 731-7052
The NPI 1790884344 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Hemoglobin a1c level (HCPCS:83036)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Assessment of emotional or behavioral problems (HCPCS:96127)
- Vitamin d-3 level (HCPCS:82306)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Blood test, clotting time (HCPCS:85610)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
- Urine microalbumin (protein) level (HCPCS:82043)
- Folic acid level, serum (HCPCS:82746)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Ferritin (blood protein) level (HCPCS:82728)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Transitional care management services for problem of moderate complexity (HCPCS:99495)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Pneumococcal vaccine, 23-valent (HCPCS:90732)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
- Uric acid level, blood (HCPCS:84550)
- Bacterial colony count, urine (HCPCS:87086)
- Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
- Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
The enumeration date for this NPI number is 9/21/2006 and was last updated on 7/8/2007.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 211481 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 02116127 | MEDICAID | NEW YORK | |
| 2 | G92562 | MEDICARE UPIN | NEW YORK | |
| 3 | 49C381 | MEDICARE ID-TYPE UNSPECIFIED | NEW YORK | |